Tissue Regs On Horizon Despite Manufacturer Concerns
This article was originally published in The Gray Sheet
Executive Summary
FDA should regulate threaded cortical bone dowels as a device, rather than a tissue, because it is indicated for a specific use, Stryker Biotech maintains in comments to the agency.
You may also be interested in...
Tissue, Cell-Based Product Reg Needs Some Clarification - FDA Staffers
FDA's proposed rule to establish regulations on human cellular or tissue-based medical equipment requires further clarification, agency staffers acknowledged.
HBV Surface Antigen Tests Required Under Proposed Tissue Reg
Manufacturers of human cellular and tissue-based products should use surface antigen tests for hepatitis B rather than core antibody HBV assays, FDA states in a Sept. 30 proposed rule.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.